Evidence map›Paper›PMID 27325287›Full record

ArticleDiabetes2016

A PPARγ-Bnip3 Axis Couples Adipose Mitochondrial Fusion-Fission Balance to Systemic Insulin Sensitivity.

Marc J Tol, Roelof Ottenhoff, Marco van Eijk, Noam Zelcer, Jan Aten, Sander M Houten, Dirk Geerts, Cindy van Roomen, Marlou C Bierlaagh, Saskia Scheij and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Marc J TolDepartment of Medical Biochemistry, University of Amsterdam, Academic Medical Centre, Amsterdam, the Netherlands.
Roelof OttenhoffDepartment of Medical Biochemistry, University of Amsterdam, Academic Medical Centre, Amsterdam, the Netherlands.
Marco van EijkDepartment of Medical Biochemistry, University of Amsterdam, Academic Medical Centre, Amsterdam, the Netherlands Leiden Institute of Chemistry, Leiden University, Leiden, the Netherlands.
Noam ZelcerDepartment of Medical Biochemistry, University of Amsterdam, Academic Medical Centre, Amsterdam, the Netherlands.
Jan AtenDepartment of Pathology, University of Amsterdam, Academic Medical Centre, Amsterdam, the Netherlands.
Sander M HoutenDepartment of Genetic Metabolic Diseases, University of Amsterdam, Academic Medical Centre, Amsterdam, the Netherlands Department of Genetics and Genomic Sciences, Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY.
Dirk GeertsDepartment of Human Genetics, University of Amsterdam, Academic Medical Centre, Amsterdam, the Netherlands.
Cindy van RoomenDepartment of Medical Biochemistry, University of Amsterdam, Academic Medical Centre, Amsterdam, the Netherlands.
Marlou C BierlaaghDepartment of Medical Biochemistry, University of Amsterdam, Academic Medical Centre, Amsterdam, the Netherlands.
Saskia ScheijDepartment of Medical Biochemistry, University of Amsterdam, Academic Medical Centre, Amsterdam, the Netherlands.
Marten A HoeksemaDepartment of Medical Biochemistry, University of Amsterdam, Academic Medical Centre, Amsterdam, the Netherlands.
Johannes M AertsLeiden Institute of Chemistry, Leiden University, Leiden, the Netherlands.
Jonathan S BoganSection of Endocrinology and Metabolism, Departments of Internal Medicine & Cell Biology, Yale University School of Medicine, New Haven, CT.
Gerald W DornCentre for Pharmacogenomics, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO.
Carmen A ArgmannDepartment of Medical Biochemistry, University of Amsterdam, Academic Medical Centre, Amsterdam, the Netherlands Department of Genetics and Genomic Sciences, Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY carmen.argmann@mssm.edu a.j.verhoeven@amc.uva.nl.
Arthur J VerhoevenDepartment of Medical Biochemistry, University of Amsterdam, Academic Medical Centre, Amsterdam, the Netherlands carmen.argmann@mssm.edu a.j.verhoeven@amc.uva.nl.
University of Amsterdam · NLLeiden University · NLWashington University in St. Louis · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
MOLECULAR MECHANISM OF APOPTOTIC CARDIOMYOPATHYR01HL059888 · NHLBI · WASHINGTON UNIVERSITY · PI DORN, GERALD W. · 1999 to 2016
$5.4M
Vesicle Translocation and the Metabolic SyndromeR01DK092661 · NIDDK · YALE UNIVERSITY · PI BOGAN, JONATHAN · 2012 to 2018
$2.0M
MOLECULAR ORCHESTRATION OF MITOCHONDRIAL FITNESS VIA REPLACEMENT OR REPAIRR01HL128441 · NHLBI · WASHINGTON UNIVERSITY · PI DORN, GERALD W. · 2016 to 2016
$381k
Vesicle Translocation and the Metabolic SyndromeR56DK092661 · NIDDK · YALE UNIVERSITY · PI BOGAN, JONATHAN · 2020 to 2020
$168k
European Research Council 617376NCATS NIH HHS UL1 TR001863NHLBI NIH HHS R01 HL059888NHLBI NIH HHS R01 HL128441NIDDK NIH HHS R01 DK092661NIDDK NIH HHS R56 DK092661
6 · The paper itself

Abstract

Aberrant mitochondrial fission plays a pivotal role in the pathogenesis of skeletal muscle insulin resistance. However, fusion-fission dynamics are physiologically regulated by inherent tissue-specific and nutrient-sensitive processes that may have distinct or even opposing effects with respect to insulin sensitivity. Based on a combination of mouse population genetics and functional in vitro assays, we describe here a regulatory circuit in which peroxisome proliferator-activated receptor γ (PPARγ), the adipocyte master regulator and receptor for the thiazolidinedione class of antidiabetic drugs, controls mitochondrial network fragmentation through transcriptional induction of Bnip3. Short hairpin RNA-mediated knockdown of Bnip3 in cultured adipocytes shifts the balance toward mitochondrial elongation, leading to compromised respiratory capacity, heightened fatty acid β-oxidation-associated mitochondrial reactive oxygen species generation, insulin resistance, and reduced triacylglycerol storage. Notably, the selective fission/Drp1 inhibitor Mdivi-1 mimics the effects of Bnip3 knockdown on adipose mitochondrial bioenergetics and glucose disposal. We further show that Bnip3 is reciprocally regulated in white and brown fat depots of diet-induced obesity and leptin-deficient ob/ob mouse models. Finally, Bnip3(-/-) mice trade reduced adiposity for increased liver steatosis and develop aggravated systemic insulin resistance in response to high-fat feeding. Together, our data outline Bnip3 as a key effector of PPARγ-mediated adipose mitochondrial network fragmentation, improving insulin sensitivity and limiting oxidative stress.

Indexed as

3T3-L1 CellsAdipocytesAnimalsCell DifferentiationCell LineFemaleGlucoseImmunoblottingImmunohistochemistryInsulinInsulin ResistanceMaleMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutBNip3 protein, mouseGlucoseInsulinMembrane ProteinsMitochondrial ProteinsPPAR gamma

Identifiers

PMID27325287
PMCPMC5001173
OpenAlexW2468402352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.